GRASSI, GUIDO
 Distribuzione geografica
Continente #
NA - Nord America 76.178
AS - Asia 44.261
EU - Europa 30.731
SA - Sud America 6.657
AF - Africa 719
OC - Oceania 114
Continente sconosciuto - Info sul continente non disponibili 67
Totale 158.727
Nazione #
US - Stati Uniti d'America 74.497
SG - Singapore 17.179
CN - Cina 9.681
HK - Hong Kong 7.907
RU - Federazione Russa 6.659
VN - Vietnam 5.379
BR - Brasile 5.374
SE - Svezia 4.190
DE - Germania 4.117
IT - Italia 3.988
IE - Irlanda 3.770
UA - Ucraina 2.694
GB - Regno Unito 1.634
CA - Canada 1.172
FI - Finlandia 964
KR - Corea 761
IN - India 732
FR - Francia 660
AR - Argentina 517
AT - Austria 488
ID - Indonesia 488
TR - Turchia 418
MX - Messico 343
BD - Bangladesh 329
NL - Olanda 305
ZA - Sudafrica 294
PL - Polonia 243
JP - Giappone 235
EC - Ecuador 232
IQ - Iraq 213
DK - Danimarca 187
ES - Italia 162
PK - Pakistan 125
CO - Colombia 118
VE - Venezuela 113
BE - Belgio 109
AU - Australia 96
SA - Arabia Saudita 91
CZ - Repubblica Ceca 90
PY - Paraguay 89
CL - Cile 80
UZ - Uzbekistan 79
MA - Marocco 75
IR - Iran 72
KE - Kenya 70
AE - Emirati Arabi Uniti 64
TN - Tunisia 64
PE - Perù 61
EG - Egitto 60
LT - Lituania 53
RO - Romania 53
TW - Taiwan 53
EU - Europa 50
GR - Grecia 50
MY - Malesia 48
PH - Filippine 45
PT - Portogallo 44
UY - Uruguay 42
NP - Nepal 40
KZ - Kazakistan 37
CH - Svizzera 36
JO - Giordania 36
AZ - Azerbaigian 34
DO - Repubblica Dominicana 34
BG - Bulgaria 32
IL - Israele 30
DZ - Algeria 27
NG - Nigeria 27
BO - Bolivia 24
TH - Thailandia 24
AL - Albania 23
TT - Trinidad e Tobago 23
ET - Etiopia 20
JM - Giamaica 20
KG - Kirghizistan 19
PA - Panama 19
SN - Senegal 19
EE - Estonia 18
HU - Ungheria 18
LB - Libano 18
NO - Norvegia 18
NZ - Nuova Zelanda 18
RS - Serbia 18
SK - Slovacchia (Repubblica Slovacca) 18
LK - Sri Lanka 17
PS - Palestinian Territory 17
LV - Lettonia 16
BA - Bosnia-Erzegovina 15
BY - Bielorussia 15
HN - Honduras 14
MK - Macedonia 14
AM - Armenia 13
BH - Bahrain 13
CR - Costa Rica 12
KH - Cambogia 12
MU - Mauritius 12
SV - El Salvador 11
A2 - ???statistics.table.value.countryCode.A2??? 10
BB - Barbados 10
CI - Costa d'Avorio 10
Totale 158.567
Città #
Ann Arbor 12.308
Singapore 8.900
Hong Kong 7.851
Fairfield 6.264
Woodbridge 6.101
Ashburn 5.344
Houston 4.598
Dublin 3.596
Chandler 3.315
Wilmington 2.887
Jacksonville 2.836
Seattle 2.603
Frankfurt am Main 2.325
Dearborn 2.032
Cambridge 2.011
New York 1.962
Ho Chi Minh City 1.666
Hefei 1.651
Princeton 1.646
Dallas 1.639
Beijing 1.378
Santa Clara 1.256
Hanoi 1.224
Milan 1.187
Los Angeles 985
Lawrence 778
Altamura 723
Moscow 719
Seoul 717
Nanjing 700
The Dalles 652
Chicago 620
Shanghai 472
Buffalo 463
São Paulo 461
Lachine 459
Hangzhou 446
San Diego 424
Vienna 364
Helsinki 329
Jakarta 319
Guangzhou 309
Andover 277
Munich 275
Boardman 263
Toronto 261
Nanchang 242
Council Bluffs 214
London 212
Shenyang 207
Hebei 191
Salt Lake City 190
Dong Ket 189
Ottawa 178
Changsha 176
Tianjin 174
Da Nang 164
Rio de Janeiro 163
Tokyo 159
Warsaw 153
Nuremberg 150
Jiaxing 142
Haiphong 141
Rome 138
Falls Church 136
Jinan 136
Norwalk 125
Orem 118
Johannesburg 116
San Jose 116
Brooklyn 113
Lissone 112
Fremont 108
Columbus 106
Atlanta 105
Brasília 104
Quận Bình Thạnh 103
Zhengzhou 101
Belo Horizonte 99
Chennai 99
Denver 97
Istanbul 97
Biên Hòa 96
Montreal 96
Elk Grove Village 95
Phoenix 92
Brussels 91
Ha Long 91
Tampa 91
Ninh Bình 89
Stockholm 89
Turku 84
Porto Alegre 83
Kunming 82
Lappeenranta 82
Hải Dương 81
Mexico City 80
Quito 80
Can Tho 78
Curitiba 76
Totale 104.326
Nome #
2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) 815
Echocardiographic Phenotypes of Subclinical Organ Damage: Clinical and Prognostic Value in the General Population. Findings from the Pamela Study 579
'Indeterminate for malignancy' (Tir3/Thy3 in the Italian and British systems for classification) thyroid fine needle aspiration (FNA) cytology reporting: Morphological criteria and clinical impact 484
Association Between Atrial, Ventricular and Vascular Morphofunctional Alterations in Rheumatoid Arthritis 476
Predictors of pwv progression over a three years follow up: focus on psychological characteristics 439
Sex-related relationships between uric acid and target organ damage in hypertension 435
Myocardial Mechanics in Acromegaly: A Meta-Analysis of Echocardiographic Studies 430
Baroreceptors as a target of device-based neuromodulation in heart failure: Long-term outcomes 428
Why were the 2023 Guidelines of the European Society of Hypertension not developed as Joint Guidelines together with the European Society of Cardiology? 417
Contrasting effects of carotid baroreceptor stimulation on regional sympathetic drive in chronic human heart failure 409
Understanding Factors Associated With Psychomotor Subtypes of Delirium in Older Inpatients With Dementia 395
Big data, observational research and P-value: a recipe for false-positive findings? A study of simulated and real prospective cohorts 383
Heart rate as a sympathetic marker during acute adrenergic challenge 379
Pulse wave velocity progression over a medium-term follow-up in hypertensives: Focus on uric acid 371
Does the 9p region affect arterial stiffness? Results from a cohort of hypertensive individuals 358
Persistence of arterial functional abnormalities after successful coronary revascularization 356
Sympathetic Overactivation in the Resistant Hypertensive Phenotype: A Meta-Analysis of Published Studies 355
Comparison of echotracking and magnetic resonance assessment of abdominal aorta distensibility and relationships with pulse wave velocity 354
Cardiopulmonary receptor modulation of plasma renin activity in normotensive and hypertensive subjects 340
Hemodynamic effects of acute and prolonged administration of nitrendipine in essential hypertension 339
Calcium antagonists and neural control of circulation in essential hypertension 332
Early alterations in left ventricular diastolic function in normotensive diabetic patients 328
In healthy normotensive subjects age and blood pressure better predict subclinical vascular and cardiac organ damage than atherosclerosis biomarkers 327
The effects of sex and method of blood pressure measurement on genetic associations with blood pressure in the PAMELA study 321
Exploration into Uric and Cardiovascular Disease: Uric Acid Right for heArt Health (URRAH) Project, A Study Protocol for a Retrospective Observational Study 320
Effects of blood-pressure measurement by the doctor on patient's blood pressure and heart rate 319
Hyperuricemia prevalence in healthy subjects and its relationship with cardiovascular target organ damage 314
Determinants of carotid-femoral pulse wave velocity progression in hypertensive patients over a 3.7 years follow-up 310
Cardiovascular Remodeling after Endovascular Treatment for Thoracic Aortic Injury 310
Diverse pharmacological properties, trial results, comorbidity prescribing and neural pathophysiology suggest European hypertension guideline downgrading of beta-blockers is not justified 306
2024 European Society of Hypertension clinical practice guidelines for the management of arterial hypertension 305
Differing associations for sport versus occupational physical activity and cardiovascular risk 304
A case of Pseudomonas Aeruginosa commercial tattoo infection 302
Gender-related differences in serum uric acid in treated hypertensive patients fromcentral and east European countries: Findings from the blood pressure control rate and cardiovascular risk profile study 297
Sympathetic Neural Overdrive in the Obese and Overweight State: Meta-Analysis of Published Studies 297
Cardiopulmonary receptor regulation of renin release 294
Statins and the risk of diabetes: Evidence from a large population-based cohort study 291
Cardiopulmonary reflex before and after regression of left ventricular hypertrophy in essential hypertension 289
Serum uric acid, predicts heart failure in a large Italian cohort: search for a cut-off value the URic acid Right for heArt Health study 288
Psychological Predictors of Arterial Stiffness Progression over a Three Years Follow Up 286
Sympathetic and baroreflex alterations in congestive heart failure with preserved, midrange and reduced ejection fraction. 283
Blood pressure response to labetalol in twice and three times daily administration during a 24‐hour period. 282
Heart rate as cardiovascular risk factor 279
Twenty-four-hour blood pressure profile and blood pressure variability in untreated hypertension and during antihypertensive treatment by once-a-day nadolol 278
Blood pressure targets in type 2 diabetes. Evidence against or in favour of an aggressive approach 277
2007 ESH-ESC guidelines for the management of arterial hypertension - The task force for the management of arterial hypertension of the European society of hypertension (ESH) and of the European society of cardiology (ESC) 276
Prognostic significance of masked tachycardia in hypertension: Evidence from a prospective international registry 276
Blood pressure and heart rate variabilities in normotensive and hypertensive human beings 275
Effect of angiotensin converting enzyme inhibition on cardiovascular regulation during reflex sympathetic activation in sodium-replete patients with essential hypertension 274
Left ventricular hypertrophy increases cardiovascular risk independently of in-office and out-of-office blood pressure values 273
Long-term risk of diabetes, hypertension and left ventricular hypertrophy associated with the metabolic syndrome in a general population 271
Similarities and differences between renal sympathetic denervation and carotid baroreceptor stimulation 270
Alterations in sympathetic nerve traffic in genetic haemochromatosis before and after iron depletion therapy: A microneurographic study 270
Reliability of heart rate as neuroadrenergic marker in the metabolic syndrome. 270
The Pamela study: main findings and perspectives 268
Effects of celiprolol on reflex control of the cardiovascular system in essential hypertension 267
Cardiovascular risk factor profile in an italian cohort of patients with rheumatoid arthritis: results of a three years follow-up 267
Prognostic relevance of electrocardiographic Tpeak-Tend interval in the general and in the hypertensive population: Data from the Pressioni Arteriose Monitorate e Loro Associazioni study 266
Twenty-four-hour hemodynamic profile during treatment of essential hypertension by once-a-day nadolol 266
Influence of cardiopulmonary receptors on the bradycardiac responses to carotid baroreceptor stimulation in man 265
Regional differences in sympathetic activation in lean and obese normotensive individuals with obstructive sleep apnoea 263
Severe systemic cytomegalovirus infection in an immunocompetent patient outside the intensive care unit: a case report 263
Left atrial volume in elite athletes: A meta-analysis of echocardiographic studies 263
Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study 262
The Big Data Era in Cardiology and Cardiovascular Medicine: Advanced Analytics for Truly Personalized Care 260
Association between uric acid and pulse wave velocity in hypertensive patients and in the general population: a systematic review and meta-analysis 260
Renal denervation in patients with end-stage renal disease and resistant hypertension on long-term haemodialysis 259
Effects of ageing on the cardiopulmonary receptor reflex in normotensive humans 258
Modification of arterial baroreflexes by captopril in essential hypertension 258
Granulomatosis with polyangiitis presenting with diffuse alveolar hemorrhage requiring extracorporeal membrane oxygenation with rapid multiorgan relapse: A case report 258
Evidence of functional and structural cardiac abnormalities in cirrhotic patients with and without ascites 257
Exploring the interplay between job strain and different domains of physical activity on the incidence of coronary heart disease in adult men 257
Clinical value of NT-proBNP assay in the emergency department for the diagnosis of heart failure (HF) in very elderly people 256
Habitual coffee consumption and risk of cardiovascular and all-cause mortality in the PAMELA hypertensive population 256
Evaluation of a slow-release clonidine preparation by direct continuous blood pressure recording in essential hypertensive patients 255
Vitamin B12 deficiency-induced pseudothrombotic microangiopathy without macrocytosis presenting with acute renal failure: a case report 255
It is never too late for a genetic disease: a case of a 79-year-old man with persistent hypokalemia 254
Clinical and prognostic value of hypertensive cardiac damage in the PAMELA Study 254
Neurogenic abnormalities in masked hypertension 253
Structural alterations of the retinal microcirculation in the "prehypertensive" high-normal blood pressure state 252
Patterns of regional sympathetic nerve traffic in preascitic and ascitic cirrhosis 252
Association of uric acid with kidney function and albuminuria: the Uric Acid Right for heArt Health (URRAH) Project 251
Metabolic syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) study: daily life blood pressure, cardiac damage, and prognosis 250
Long-term sympathoinhibitory effects of surgically induced weight loss in severe obese patients 249
Cancer risk associated with use of metformin and sulfonylurea in type 2 diabetes: A meta-analysis 248
Mechanisms of antihypertensive action of beta-adrenergic blocking drugs: evidence against potentiation of baroreflexes 247
Sympathetic and baroreflex abnormalities in the uncomplicated prediabetic state 247
Neuroadrenergic and reflex abnormalities in patients with metabolic syndrome 246
Pulse wave velocity progressione over a 3.7 years follow-up: focus on metabolic syndrome. 246
Cardiac, neuroadrenergic, and portal hemodynamic effects of prolonged aldosterone blockade in postviral child a cirrhosis 245
Body fat mass is a strong and negative predictor of peak stimulated growth hormone and bone mineral density in healthy adolescents during transition period 245
Two-Drug Combinations as First-Step Antihypertensive Treatment 245
Application of non-HDL cholesterol for population-based cardiovascular risk stratification: results from the Multinational Cardiovascular Risk Consortium 245
Excessive sympathetic activation in heart failure with obesity and metabolic syndrome: Characteristics and mechanisms 243
[Are plasma catecholamine levels capable of reflecting even small variations in sympathetic activity?] 242
Sympathetic overdrive in the metabolic syndrome: meta-analysis of published studies 241
Baroreflex and non-baroreflex modulation of vagal cardiac control after myocardial infarction 240
Continuation of the ESH-CHL-SHOT trial after publication of the SPRINT: Rationale for further study on blood pressure targets of antihypertensive treatment after stroke 239
Differential effects of enalapril-felodipine versus enalapril-lercanidipine combination drug treatment on sympathetic nerve traffic and metabolic profile in obesity-related hypertension 238
Prevalence of cardiovascular risk factors in an unselected Italian population. Results of the CardioLab Project 2004-2008 237
Totale 30.184
Categoria #
all - tutte 573.991
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 573.991


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20217.934 0 0 0 0 0 0 1.737 1.478 1.203 1.537 784 1.195
2021/202210.935 791 951 1.293 930 814 744 526 679 638 762 978 1.829
2022/202314.314 2.112 4.076 1.131 1.153 862 2.360 194 817 889 109 400 211
2023/202411.472 322 293 482 532 1.772 2.742 2.129 325 1.204 226 212 1.233
2024/202531.683 1.760 3.941 1.278 1.366 2.575 926 1.539 1.204 3.523 4.124 3.456 5.991
2025/202639.284 8.086 5.966 5.890 7.638 7.574 3.917 213 0 0 0 0 0
Totale 162.220